AstraZeneca's Research Focuses Heavily on Precision Medicine, Plans 20 New Drugs

AstraZeneca reports that over 90% of its current research is based on precision medicine, reflecting a strategic shift in its drug development. The company's global plans include launching 20 new medications before the end of the decade.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

la-vanguardiaSpanish70d ago

“Más del 90% de nuestra investigación ya se basa en medicina de precisión”

Los planes globales de AstraZeneca incluyen lanzar 20 nuevos medicamentos antes del final de la década

Read full article →

PERSPECTA

PERSPECTA

AstraZeneca's Research Focuses Heavily on Precision Medicine, Plans 20 New Drugs

Sources

“Más del 90% de nuestra investigación ya se basa en medicina de precisión”

Related Stories

Oldest Plague Outbreak Discovered in Siberia, Dating Back 5,500 Years

Extreme Training: What Heat Training Does to the Body

Alytus Hospital Contracts Funeral Services for Deceased Body Management

Mid-Life Obesity Linked to Alzheimer's Changes, Norwegian Study Finds

PERSPECTA